Publication | Open Access
Antibody-Derived<i>In Vivo</i>Imaging of Tau Pathology
68
Citations
34
References
2014
Year
EngineeringTau PathologyImmunologyPathologyNeurochemical BiomarkersParent Tau AntibodyVivo Brain SignalAlzheimer's DiseaseDegenerative PathologyProtein MisfoldingAutoantibodiesAntibody EngineeringNeuropathologyNeuroimmunologyMolecular ImagingAutoimmune DiseaseHistopathologyAutoimmunityAntibody ScreeningCell BiologyProtective MechanismsAntibody BiologyNeurodegenerative DiseasesBiomedical ImagingTau LesionsBiomarkersMedicine
Antibodies or their derivatives as imaging probes for pathological tau protein have great potential, but have not been well studied. In particular, smaller, single-chain-variable antibody fragments (scFv's) are attractive for detecting tau lesions in live subjects. Here, we generated libraries of scFv's and identified numerous phospho-tau-selective scFv's. Peripheral injection of one of these scFv's consistently resulted in a strong in vivo brain signal in transgenic tauopathy mice, but not in wild-type or amyloid-β plaque mice. The parent tau antibody provided similar results, albeit with a weaker signal intensity. The imaging signal correlated very well with colocalization of the probe with intraneuronal tau aggregates. Both were associated with markers of endosomes, autophagosomes, and lysosomes, suggesting their interaction in these degradation pathways. Such specific antibody-derived imaging probes have great potential as diagnostic markers for Alzheimer's disease and related tauopathies.
| Year | Citations | |
|---|---|---|
Page 1
Page 1